What is CJC-1295 (No DAC)?
CJC-1295 (No DAC) is a short-acting analog of growth hormone-releasing hormone (GHRH) that has been studied for its potential to stimulate endogenous growth hormone (GH) secretion in a controlled and natural pulsatile fashion. Unlike its DAC counterpart, this version of CJC-1295 provides a shorter duration of action, making it an ideal research compound for studying natural GH rhythms.
Mechanism of Interest
CJC-1295 (No DAC) binds to GHRH receptors in the pituitary gland and promotes growth hormone secretion without significantly altering the body’s natural release cycles. It has been studied in combination with other secretagogues like Ipamorelin to evaluate synergistic effects in preclinical models.
Why Researchers Study CJC-1295 (No DAC)
- Explored for supporting natural growth hormone release and IGF-1 elevation
- Used in models studying muscle recovery, metabolism, and cellular repair
- Preferred in protocols where shorter biological activity is desired
Reviews
There are no reviews yet.